These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 2086120)
41. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors. de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422 [TBL] [Abstract][Full Text] [Related]
42. DNA-malignancy-grading of bladder tumor and its clinical significance. Wang XZ; Ma YJ; Zheng JF; Qin HY Chin Med J (Engl); 1992 Oct; 105(10):856-9. PubMed ID: 1291205 [TBL] [Abstract][Full Text] [Related]
43. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. al-Abadi H; Nagel R J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829 [TBL] [Abstract][Full Text] [Related]
44. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. van Velthoven R; Petein M; Oosterlinck WJ; Zandona C; Zlotta A; Van der Meijden AP; Pasteels JL; Roels H; Schulman C; Kiss R Hum Pathol; 1995 Jan; 26(1):3-11. PubMed ID: 7821913 [TBL] [Abstract][Full Text] [Related]
45. DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO). Lipponen PK; Eskelinen MJ; Collan Y; Pesonen E; Ventilä T; Sotarauta M; Nordling S Urol Int; 1990; 45(1):4-9. PubMed ID: 2305493 [TBL] [Abstract][Full Text] [Related]
46. [Flow cytofluorometric DNA analysis in fresh bladder specimens and its correlations between cytology and mitotic index]. Song LF Zhonghua Wai Ke Za Zhi; 1990 May; 28(5):289-91, 318. PubMed ID: 2086099 [TBL] [Abstract][Full Text] [Related]
47. A retrospective study of DNA ploidy of transitional cell carcinoma of urinary bladder using flow cytometry. Pan ST; Chan LP; Yu KC; Chang MC; Ho WL Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jan; 10(1):22-7. PubMed ID: 8176764 [TBL] [Abstract][Full Text] [Related]
48. [Flow cytometric analysis of the DNA content in the urinary bladder cancers treated by radical cystectomy and pre-operative irradiation]. Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Togashi M; Koyanagi T; Nojima T; Inoue K Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):2050-7. PubMed ID: 1474714 [TBL] [Abstract][Full Text] [Related]
49. Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA J Urol; 1990 Oct; 144(4):884-7. PubMed ID: 2398563 [TBL] [Abstract][Full Text] [Related]
50. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues. Wu L; Lochhead A; Yang J; Ow KT; Russell PJ Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732 [TBL] [Abstract][Full Text] [Related]
51. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. Slaton JW; Dinney CP; Veltri RW; Miller CM; Liebert M; O'Dowd GJ; Grossman HB J Urol; 1997 Sep; 158(3 Pt 1):806-11. PubMed ID: 9258087 [TBL] [Abstract][Full Text] [Related]
52. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. Hug EB; Donnelly SM; Shipley WU; Heney NM; Kaufman DS; Preffer FI; Schwartz SM; Colvin RB; Althausen AF J Urol; 1992 Jul; 148(1):47-51. PubMed ID: 1613879 [TBL] [Abstract][Full Text] [Related]
53. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333 [TBL] [Abstract][Full Text] [Related]
54. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry. Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834 [TBL] [Abstract][Full Text] [Related]
55. Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer. Tachibana M; Deguchi N; Jitsukawa S; Baba S; Hata M; Tazaki H J Urol; 1991 May; 145(5):963-7. PubMed ID: 2016810 [TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder. Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234 [TBL] [Abstract][Full Text] [Related]
57. Comparison of image analysis and flow cytometric measurements of DNA content of canine transitional cell carcinomas. Clemo FA; Crabtree WN; Walker E; DeNicola DB Anal Quant Cytol Histol; 1993 Dec; 15(6):418-26. PubMed ID: 8297432 [TBL] [Abstract][Full Text] [Related]
58. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time. Borgström E; Gustafson H Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504 [TBL] [Abstract][Full Text] [Related]
59. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy. Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008 [TBL] [Abstract][Full Text] [Related]
60. Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidy. Campanella R; Russo A; Plaja S; Bazan V; Pavone C; Corselli G; Pavone-Macaluso M Eur Urol; 1992; 21(1):58-63. PubMed ID: 1606985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]